Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 16

1.

Nerve injection of viral vectors efficiently transfers transgenes into motor neurons and delivers RNAi therapy against ALS.

Wu R, Wang H, Xia X, Zhou H, Liu C, Castro M, Xu Z.

Antioxid Redox Signal. 2009 Jul;11(7):1523-34. doi: 10.1089/ARS.2009.2618.

2.

Current developments in gene therapy for amyotrophic lateral sclerosis.

Scarrott JM, Herranz-Martín S, Alrafiah AR, Shaw PJ, Azzouz M.

Expert Opin Biol Ther. 2015 Jul;15(7):935-47. doi: 10.1517/14712598.2015.1044894. Review.

PMID:
25959569
3.

Research advances in gene therapy approaches for the treatment of amyotrophic lateral sclerosis.

Nizzardo M, Simone C, Falcone M, Riboldi G, Rizzo F, Magri F, Bresolin N, Comi GP, Corti S.

Cell Mol Life Sci. 2012 May;69(10):1641-50. doi: 10.1007/s00018-011-0881-5. Review.

PMID:
22094924
4.

[Gene therapy of ALS with RNA interference].

Yokota T.

Rinsho Shinkeigaku. 2009 Nov;49(11):821-3. Review. Japanese.

PMID:
20030220
5.

Gene Therapy for ALS: progress and prospects.

Azzouz M.

Biochim Biophys Acta. 2006 Nov-Dec;1762(11-12):1122-7. Review.

6.

Transgenics, toxicity and therapeutics in rodent models of mutant SOD1-mediated familial ALS.

Turner BJ, Talbot K.

Prog Neurobiol. 2008 May;85(1):94-134. doi: 10.1016/j.pneurobio.2008.01.001. Review.

PMID:
18282652
7.

[Gene therapy of ALS with short interfering RNA].

Yokota T.

Brain Nerve. 2007 Oct;59(10):1187-94. Review. Japanese.

PMID:
17969360
8.

RNAi silencing in mouse models of neurodegenerative diseases.

Farah MH.

Curr Drug Deliv. 2007 Apr;4(2):161-7. Review.

PMID:
17456035
9.

Genetics of amyotrophic lateral sclerosis.

Siddique T, Deng HX.

Hum Mol Genet. 1996;5 Spec No:1465-70. Review.

PMID:
8875253
10.

Aberrant regulation of DNA methylation in amyotrophic lateral sclerosis: a new target of disease mechanisms.

Martin LJ, Wong M.

Neurotherapeutics. 2013 Oct;10(4):722-33. doi: 10.1007/s13311-013-0205-6. Review.

11.

Gene therapy for amyotrophic lateral sclerosis and other motor neuron diseases.

Alisky JM, Davidson BL.

Hum Gene Ther. 2000 Nov 20;11(17):2315-29. Review.

PMID:
11096437
12.

AAV as a gene transfer vector for the treatment of neurological disorders: novel treatment thoughts for ALS.

Hester ME, Foust KD, Kaspar RW, Kaspar BK.

Curr Gene Ther. 2009 Oct;9(5):428-33. Review.

PMID:
19860657
13.

Gene therapy for ALS delivers.

Boillée S, Cleveland DW.

Trends Neurosci. 2004 May;27(5):235-8. Review.

PMID:
15111001
14.

Amyotrophic lateral sclerosis and gene therapy.

Miller TM, Smith RA, Cleveland DW.

Nat Clin Pract Neurol. 2006 Sep;2(9):462-3. Review. No abstract available.

PMID:
16932606
15.

Recombinant AAV as a platform for translating the therapeutic potential of RNA interference.

Borel F, Kay MA, Mueller C.

Mol Ther. 2014 Apr;22(4):692-701. doi: 10.1038/mt.2013.285. Review.

16.

RNAi and gene therapy: a mutual attraction.

Grimm D, Kay MA.

Hematology Am Soc Hematol Educ Program. 2007:473-81. Review.

PMID:
18024667
Items per page

Supplemental Content

Support Center